Aptabio Ranks High in Searches... Stock Price Up 5.1%
Aptabio has ranked among the top searched stocks on 4 days within the past month.
As of 11:30 AM on the 7th, Aptabio is trading at 76,200 KRW, up 5.1% from the previous day. This marks a 103.2% increase compared to December 11.
Over the past 5 days, individual investors have net purchased 205,636 shares, while foreign investors and institutions have net sold 76,892 shares and 116,421 shares, respectively.
On January 6, Aptabio became a market issue with a surge in price due to its "COVID-19 treatment drug FDA Phase 2 clinical trial application."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※Source: AI investment assistant AI Rasero
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
